Canada Genotyping Market Size & Outlook, 2023-2030
Canada genotyping market, 2018-2030 (US$M)
Related Markets
Canada genotyping market highlights
- The Canada genotyping market generated a revenue of USD 653.4 million in 2023 and is expected to reach USD 1,778.2 million by 2030.
- The Canada market is expected to grow at a CAGR of 15.4% from 2024 to 2030.
- In terms of segment, reagents & kits was the largest revenue generating product in 2023.
- Reagents & kits is the most lucrative product segment registering the fastest growth during the forecast period.
Genotyping market data book summary
| Market revenue in 2023 | USD 653.4 million |
| Market revenue in 2030 | USD 1,778.2 million |
| Growth rate | 15.4% (CAGR from 2023 to 2030) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & kits |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & kits, Services |
| Key market players worldwide | Illumina Inc, Thermo Fisher Scientific Inc, Qiagen NV, Roche, Fluidigm Corporation, Danaher Corp, Agilent Technologies, Eurofins Scientific SE, GE HealthCare Technologies Inc Common Stock, Bio-Rad Laboratories Inc |
Other key industry trends
- In terms of revenue, Canada accounted for 3.6% of the global genotyping market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. genotyping market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,778.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genotyping Market Scope
Genotyping Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada genotyping market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genotyping market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 81.86% in 2023. Horizon Databook has segmented the Canada genotyping market based on instruments, reagents & kits, services covering the revenue growth of each sub-segment from 2018 to 2030.
Rising initiatives undertaken by the government and private organizations in genomic research and development in Canada are expected to drive market growth. Organizations, such as the Canadian Dairy Network (CDN), initiated genomic programs for dairy cattle in Canada.
Around 75% of the total cattle herds in Canada are a part of breed improvement programs of CDN. Through this program, dairy farmer’s return on investment and productivity are expected to increase substantially. Approximately 10% of the newborn heifers are genotyped.
Furthermore, to capitalize on this opportunity, key players, such as Illumina, have an active presence in the market through their dedicated product portfolios for bovine genotyping, like Bovine SNP50 BeadChip, TruSeq Bovine parentage sequencing panel, and GeneSeek genome profiler bovine 150K array. Such initiatives are expected to drive the market.
Reasons to subscribe to Canada genotyping market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada genotyping market databook
-
Our clientele includes a mix of genotyping market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada genotyping market , including forecasts for subscribers. This country databook contains high-level insights into Canada genotyping market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada genotyping market size, by product, 2018-2030 (US$M)
Canada Genotyping Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
